Putnam Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $14.2M | Sell |
491,568
-226,089
| -32% | -$6.83M | 0.02% | 276 |
|
|
2023
Q3 | $23.8M | Sell |
717,657
-300,533
| -30% | -$10.6M | 0.04% | 184 |
|
|
2023
Q2 | $37.3M | Sell |
1,018,190
-78,300
| -7% | -$3.05M | 0.06% | 161 |
|
|
2023
Q1 | $44.7M | Sell |
1,096,490
-718,428
| -40% | -$31M | 0.07% | 152 |
|
|
2022
Q4 | $93M | Sell |
1,814,918
-175,193
| -9% | -$8.4M | 0.16% | 119 |
|
|
2022
Q3 | $87.1M | Sell |
1,990,111
-476,587
| -19% | -$23.2M | 0.17% | 118 |
|
|
2022
Q2 | $129M | Buy |
2,466,698
+67,024
| +3% | +$3.42M | 0.23% | 106 |
|
|
2022
Q1 | $124M | Buy |
2,399,674
+304,175
| +15% | +$15.8M | 0.19% | 114 |
|
|
2021
Q4 | $124M | Sell |
2,095,499
-2,207,626
| -51% | -$109M | 0.18% | 119 |
|
|
2021
Q3 | $185M | Buy |
4,303,125
+15,424
| +0.4% | +$683K | 0.29% | 100 |
|
|
2021
Q2 | $168M | Sell |
4,287,701
-44,652
| -1% | -$1.74M | 0.26% | 104 |
|
|
2021
Q1 | $157M | Sell |
4,332,353
-362,327
| -8% | -$12.9M | 0.26% | 103 |
|
|
2020
Q4 | $173M | Sell |
4,694,680
-1,290,165
| -22% | -$47.3M | 0.31% | 89 |
|
|
2020
Q3 | $208M | Sell |
5,984,845
-22,752
| -0.4% | -$798K | 0.41% | 68 |
|
|
2020
Q2 | $186M | Sell |
6,007,597
-934,294
| -13% | -$31.7M | 0.4% | 75 |
|
|
2020
Q1 | $215M | Buy |
6,941,891
+608,275
| +10% | +$20.7M | 0.56% | 46 |
|
|
2019
Q4 | $235M | Buy |
6,333,616
+31,735
| +0.5% | +$1.13M | 0.48% | 55 |
|
|
2019
Q3 | $215M | Sell |
6,301,881
-24,889
| -0.4% | -$905K | 0.48% | 56 |
|
|
2019
Q2 | $260M | Sell |
6,326,770
-628,831
| -9% | -$25M | 0.58% | 48 |
|
|
2019
Q1 | $280M | Buy |
6,955,601
+109,099
| +2% | +$4.37M | 0.65% | 37 |
|
|
2018
Q4 | $284M | Buy |
6,846,502
+117,281
| +2% | +$4.87M | 0.75% | 31 |
|
|
2018
Q3 | $281M | Buy |
6,729,221
+13,488
| +0.2% | +$519K | 0.61% | 41 |
|
|
2018
Q2 | $231M | Buy |
6,715,733
+571,030
| +9% | +$19.5M | 0.53% | 51 |
|
|
2018
Q1 | $207M | Sell |
6,144,703
-360,262
| -6% | -$12.4M | 0.48% | 58 |
|
|
2017
Q4 | $224M | Buy |
6,504,965
+308,329
| +5% | +$10.5M | 0.5% | 51 |
|
|
2017
Q3 | $210M | Sell |
6,196,636
-431,341
| -7% | -$13.9M | 0.48% | 51 |
|
|
2017
Q2 | $211M | Sell |
6,627,977
-1,752,057
| -21% | -$55.3M | 0.49% | 49 |
|
|
2017
Q1 | $272M | Sell |
8,380,034
-1,644,858
| -16% | -$51.9M | 0.64% | 34 |
|
|
2016
Q4 | $309M | Sell |
10,024,892
-78,746
| -0.8% | -$2.4M | 0.75% | 27 |
|
|
2016
Q3 | $325M | Buy |
10,103,638
+1,283,771
| +15% | +$42.9M | 0.78% | 28 |
|
|
2016
Q2 | $295M | Sell |
8,819,867
-2,207,656
| -20% | -$70.5M | 0.72% | 31 |
|
|
2016
Q1 | $310M | Sell |
11,027,523
-129,680
| -1% | -$3.7M | 0.74% | 28 |
|
|
2015
Q4 | $342M | Buy |
11,157,203
+27,926
| +0.3% | +$879K | 0.77% | 29 |
|
|
2015
Q3 | $332M | Buy |
11,129,277
+13,634
| +0.1% | +$437K | 0.74% | 28 |
|
|
2015
Q2 | $354M | Buy |
11,115,643
+101,175
| +0.9% | +$3.3M | 0.71% | 30 |
|
|
2015
Q1 | $364M | Buy |
11,014,468
+856,337
| +8% | +$27.2M | 0.73% | 25 |
|
|
2014
Q4 | $300M | Sell |
10,158,131
-556,246
| -5% | -$15.9M | 0.62% | 28 |
|
|
2014
Q3 | $301M | Sell |
10,714,377
-873,657
| -8% | -$24.5M | 0.64% | 33 |
|
|
2014
Q2 | $326M | Sell |
11,588,034
-278,119
| -2% | -$7.93M | 0.7% | 22 |
|
|
2014
Q1 | $362M | Sell |
11,866,153
-212,674
| -2% | -$6.34M | 0.82% | 19 |
|
|
2013
Q4 | $351M | Sell |
12,078,827
-475,745
| -4% | -$13.8M | 0.84% | 18 |
|
|
2013
Q3 | $342M | Sell |
12,554,572
-508,168
| -4% | -$13.8M | 0.91% | 12 |
|
|
2013
Q2 | $347M | Buy |
+13,062,740
| New | +$361M | 1.01% | 9 |
|
Other funds holding PFE
Putnam Investments's PFE Position: Q4 2023 in Review
Putnam Investments reduced its Pfizer (PFE) stake by 32% in Q4 2023, selling an estimated $6.83M and leaving 491,568 shares worth $14.2M. The position accounts for 0.02% of the portfolio, ranked #276.
Putnam Investments first reported a position in PFE in Q2 2013 and has held it in 43 quarters since. The position peaked at $364M in Q1 2015. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Putnam Investments held 491,568 shares of Pfizer worth $14.2M as of Q4 2023.
- Putnam Investments sold 226,089 Pfizer shares in Q4 2023, an estimated $6.83M.
- Pfizer made up 0.02% of Putnam Investments's portfolio in Q4 2023, its #276 holding.
- Putnam Investments first reported a position in Pfizer in Q2 2013 and has held it in 43 quarters since.
- Putnam Investments's Pfizer position peaked at $364M in Q1 2015.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.